![Adam Craig](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adam Craig
Chief Executive Officer at
X4 PHARMACEUTICALS, INC.
Net worth: 402 582 $ as of 2026-06-29
Profile
Adam R.
Craig currently serves as Executive Chairman, President & CEO at X4 Pharmaceuticals, Inc. since 2025.
Also holds the position of Chairman at Stratus Therapeutics, Inc. starting in 2025.
Holds memberships at The Royal College of Physicians and The Royal College of Paediatrics & Child Health.
Formerly worked at CTI BioPharma Corp.
from 2017 to 2023 as President, CEO, Director & Chief Medical Officer.
Worked at ArQule, Inc. as Medical Director & Vice President.
Served as Senior Director at ILEX Oncology, Inc. From 2012 to 2016, was Chief Medical Officer & Executive VP-Development at Sunesis Pharmaceuticals, Inc. Held the role of Founding Chief Medical Officer & Vice President at Innovive Pharmaceuticals, Inc. in 2007.
From 2007 to 2011, was Chief Medical Officer & Senior Vice President at ChemGenex Pharmaceuticals Pty Ltd. Also served as Chief Medical Officer & Senior Vice President at ChemGenex Pharmaceuticals, Inc. from 2008 to 2012.
Education includes a doctorate from the University of Leeds, an MBA from The Open University Business School, and a doctorate from Charing Cross Hospital Medical School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-02-28 | 86,206 ( 0.09% ) | 402 582 $ | 2026-06-29 |
Adam Craig active positions
| Companies | Position | Start |
|---|---|---|
| X4 PHARMACEUTICALS, INC. | Chief Executive Officer | - |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2011-01-05 |
The Royal College of Paediatrics & Child Health
 The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Garuda Therapeutics, Inc.
 Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Chairman | 2025-03-02 |
Former positions of Adam Craig
| Companies | Position | End |
|---|---|---|
| CTI BIOPHARMA CORP. | Chief Executive Officer | 2023-05-31 |
| VIRACTA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2015-12-31 |
ChemGenex Pharmaceuticals, Inc.
 ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Chief Tech/Sci/R&D Officer | 2011-12-31 |
ChemGenex Pharmaceuticals Pty Ltd.
 ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Chief Tech/Sci/R&D Officer | 2011-11-30 |
Innovive Pharmaceuticals, Inc.
 Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Chief Tech/Sci/R&D Officer | 2007-09-29 |
Training of Adam Craig
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
14
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
CTI BioPharma Corp.
 CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology Engages in acquisition, development and commercialization of novel targeted therapies for blood-related cancers | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
ILEX Oncology, Inc.
 ILEX Oncology, Inc. BiotechnologyHealth Technology Develops drugs to treat and prevent cancer | Health Technology |
Sunesis Pharmaceuticals, Inc.
 Sunesis Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology therapeutics for treatment of solid and hematologic cancers | Health Technology |
Innovive Pharmaceuticals, Inc.
Innovive Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
ChemGenex Pharmaceuticals Pty Ltd.
ChemGenex Pharmaceuticals Pty Ltd. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
University of Leeds
 University of Leeds Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ChemGenex Pharmaceuticals, Inc.
ChemGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceuticals | Health Technology |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Paediatrics & Child Health
The Royal College of Paediatrics & Child Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Open University Business School
 The Open University Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
X4 Pharmaceuticals, Inc.
 X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Charing Cross Hospital Medical School
 Charing Cross Hospital Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Develops hematopoietic stem cell therapies to treat severe and life-threatening diseases | Health Technology |
- Stock Market
- Insiders
- Adam Craig
Choose MarketScreener 
